Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

10.10
Delayed Data
As of Aug 23
 -0.20 / -1.94%
Today’s Change
6.96
Today|||52-Week Range
19.63
-41.72%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close10.30
Today’s open10.36
Day’s range10.00 - 10.38
Volume1,113,590
Average volume (3 months)1,352,603
Market cap$1.3B
Dividend yield--
Data as of 08/23/2016

Growth & Valuation

Earnings growth (last year)+55.36%
Earnings growth (this year)-263.75%
Earnings growth (next 5 years)--
Revenue growth (last year)+79.28%
P/E ratioNM
Price/Sales16.26
Price/Book30.70

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...-0.32-1.06%
FPRXFive Prime Therapeut...-0.07-0.14%
RLYPRelypsa Inc-0.02-0.06%
XLRNAcceleron Pharma Inc+0.14+0.45%
Data as of 08/23/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$135.1M
Annual profit (last year)-$32.2M
Net profit margin-23.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

Partner Offers

Search for Jobs